{"title":"Myasthenia Gravis","authors":"James M Gilchrist MD","doi":"10.1016/S1082-7579(98)00014-4","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Myasthenia gravis is an autoimmune disease caused by antibodies directed against the </span>acetylcholine receptor<span> at the neuromuscular junction, resulting in fatigable weakness of </span></span>skeletal muscles<span><span>. Effects on central cholinergic pathways and neuropsychologic function are controversial. This article will review the diagnosis of myasthenia gravis, using clinical, historical, pharmacologic, </span>electrodiagnostic<span>, and immunologic methods, and the treatment of myasthenia, both symptomatic and immunosuppressive. The effect of various medications on myasthenia gravis will also be reviewed to help prevent inadvertant acute exacerbation or unmasking of the disease.</span></span></p></div>","PeriodicalId":100909,"journal":{"name":"Medical Update for Psychiatrists","volume":"3 4","pages":"Pages 113-118"},"PeriodicalIF":0.0000,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1082-7579(98)00014-4","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Update for Psychiatrists","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1082757998000144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Myasthenia gravis is an autoimmune disease caused by antibodies directed against the acetylcholine receptor at the neuromuscular junction, resulting in fatigable weakness of skeletal muscles. Effects on central cholinergic pathways and neuropsychologic function are controversial. This article will review the diagnosis of myasthenia gravis, using clinical, historical, pharmacologic, electrodiagnostic, and immunologic methods, and the treatment of myasthenia, both symptomatic and immunosuppressive. The effect of various medications on myasthenia gravis will also be reviewed to help prevent inadvertant acute exacerbation or unmasking of the disease.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
